Global Nimodipine Sustained Release Tablets Market Growth 2021-2026

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Nimodipine Sustained Release Tablets Consumption 2016-2026

2.1.2 Nimodipine Sustained Release Tablets Consumption CAGR by Region

2.2 Nimodipine Sustained Release Tablets Segment by Type

2.2.1 30mg/Piece

2.2.2 60mg/Piece

2.2.3 Others

2.3 Nimodipine Sustained Release Tablets Sales by Type

2.3.1 Global Nimodipine Sustained Release Tablets Sales Market Share by Type (2016-2021)

2.3.2 Global Nimodipine Sustained Release Tablets Revenue and Market Share by Type (2016-2021)

2.3.3 Global Nimodipine Sustained Release Tablets Sale Price by Type (2016-2021)

2.4 Nimodipine Sustained Release Tablets Segment by Application

2.4.1 Hospital

2.4.2 Pharmacy

2.4.3 Others

2.5 Nimodipine Sustained Release Tablets Sales by Application

2.5.1 Global Nimodipine Sustained Release Tablets Sale Market Share by Application (2016-2021)

2.5.2 Global Nimodipine Sustained Release Tablets Revenue and Market Share by Application (2016-2021)

2.5.3 Global Nimodipine Sustained Release Tablets Sale Price by Application (2016-2021)

3 Global Nimodipine Sustained Release Tablets by Company

3.1 Global Nimodipine Sustained Release Tablets Sales Market Share by Company

3.1.1 Global Nimodipine Sustained Release Tablets Sales by Company (2019-2021)

3.1.2 Global Nimodipine Sustained Release Tablets Sales Market Share by Company (2019-2021)

3.2 Global Nimodipine Sustained Release Tablets Revenue Market Share by Company

3.2.1 Global Nimodipine Sustained Release Tablets Revenue by Company (2019-2021)

3.2.2 Global Nimodipine Sustained Release Tablets Revenue Market Share by Company (2019-2021)

3.3 Global Nimodipine Sustained Release Tablets Sale Price by Company

3.4 Global Manufacturers Nimodipine Sustained Release Tablets Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Nimodipine Sustained Release Tablets Product Location Distribution

3.4.2 Players Nimodipine Sustained Release Tablets Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Nimodipine Sustained Release Tablets by Region

4.1 Global Nimodipine Sustained Release Tablets by Region

4.1.1 Global Nimodipine Sustained Release Tablets Sales by Region

4.1.2 Global Nimodipine Sustained Release Tablets Revenue by Region

4.2 Americas Nimodipine Sustained Release Tablets Sales Growth

4.3 APAC Nimodipine Sustained Release Tablets Sales Growth

4.4 Europe Nimodipine Sustained Release Tablets Sales Growth

4.5 Middle East & Africa Nimodipine Sustained Release Tablets Sales Growth

5 Americas

5.1 Americas Nimodipine Sustained Release Tablets Sales by Country

5.1.1 Americas Nimodipine Sustained Release Tablets Sales by Country (2016-2021)

5.1.2 Americas Nimodipine Sustained Release Tablets Revenue by Country (2016-2021)

5.2 Americas Nimodipine Sustained Release Tablets Sales by Type

5.3 Americas Nimodipine Sustained Release Tablets Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Nimodipine Sustained Release Tablets Sales by Region

6.1.1 APAC Nimodipine Sustained Release Tablets Sales by Region (2016-2021)

6.1.2 APAC Nimodipine Sustained Release Tablets Revenue by Region (2016-2021)

6.2 APAC Nimodipine Sustained Release Tablets Sales by Type

6.3 APAC Nimodipine Sustained Release Tablets Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Nimodipine Sustained Release Tablets by Country

7.1.1 Europe Nimodipine Sustained Release Tablets Sales by Country (2016-2021)

7.1.2 Europe Nimodipine Sustained Release Tablets Revenue by Country (2016-2021)

7.2 Europe Nimodipine Sustained Release Tablets Sales by Type

7.3 Europe Nimodipine Sustained Release Tablets Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Nimodipine Sustained Release Tablets by Country

8.1.1 Middle East & Africa Nimodipine Sustained Release Tablets Sales by Country (2016-2021)

8.1.2 Middle East & Africa Nimodipine Sustained Release Tablets Revenue by Country (2016-2021)

8.2 Middle East & Africa Nimodipine Sustained Release Tablets Sales by Type

8.3 Middle East & Africa Nimodipine Sustained Release Tablets Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Nimodipine Sustained Release Tablets Distributors

10.3 Nimodipine Sustained Release Tablets Customer

11 Global Nimodipine Sustained Release Tablets Market Forecast

11.1 Global Nimodipine Sustained Release Tablets Forecast by Region

11.1.1 Global Nimodipine Sustained Release Tablets Forecast by Regions (2021-2026)

11.2.2 Global Nimodipine Sustained Release Tablets Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Nimodipine Sustained Release Tablets Forecast by Type

11.7 Global Nimodipine Sustained Release Tablets Forecast by Application

12 Key Players Analysis

12.1 Bionpharma

12.1.1 Bionpharma Company Information

12.1.2 Bionpharma Nimodipine Sustained Release Tablets Product Offered

12.1.3 Bionpharma Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Bionpharma Main Business Overview

12.1.5 Bionpharma Latest Developments

12.2 Arbor Pharmaceuticals

12.2.1 Arbor Pharmaceuticals Company Information

12.2.2 Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Product Offered

12.2.3 Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Arbor Pharmaceuticals Main Business Overview

12.2.5 Arbor Pharmaceuticals Latest Developments

12.3 Sofgen Pharmaceuticals

12.3.1 Sofgen Pharmaceuticals Company Information

12.3.2 Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Product Offered

12.3.3 Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Sofgen Pharmaceuticals Main Business Overview

12.3.5 Sofgen Pharmaceuticals Latest Developments

12.4 Pharmaceutics International

12.4.1 Pharmaceutics International Company Information

12.4.2 Pharmaceutics International Nimodipine Sustained Release Tablets Product Offered

12.4.3 Pharmaceutics International Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Pharmaceutics International Main Business Overview

12.4.5 Pharmaceutics International Latest Developments

12.5 Heritage Pharmaceuticals

12.5.1 Heritage Pharmaceuticals Company Information

12.5.2 Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Product Offered

12.5.3 Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Heritage Pharmaceuticals Main Business Overview

12.5.5 Heritage Pharmaceuticals Latest Developments

12.6 Bayer Vital

12.6.1 Bayer Vital Company Information

12.6.2 Bayer Vital Nimodipine Sustained Release Tablets Product Offered

12.6.3 Bayer Vital Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Bayer Vital Main Business Overview

12.6.5 Bayer Vital Latest Developments

12.7 Wuhan HITECK Biopharmaceutical

12.7.1 Wuhan HITECK Biopharmaceutical Company Information

12.7.2 Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Product Offered

12.7.3 Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Wuhan HITECK Biopharmaceutical Main Business Overview

12.7.5 Wuhan HITECK Biopharmaceutical Latest Developments

12.8 Qilu Pharmaceutical

12.8.1 Qilu Pharmaceutical Company Information

12.8.2 Qilu Pharmaceutical Nimodipine Sustained Release Tablets Product Offered

12.8.3 Qilu Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Qilu Pharmaceutical Main Business Overview

12.8.5 Qilu Pharmaceutical Latest Developments

12.9 Yabao Pharmaceutical Group

12.9.1 Yabao Pharmaceutical Group Company Information

12.9.2 Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Product Offered

12.9.3 Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Yabao Pharmaceutical Group Main Business Overview

12.9.5 Yabao Pharmaceutical Group Latest Developments

12.10 Sihuan Pharmaceutical

12.10.1 Sihuan Pharmaceutical Company Information

12.10.2 Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Product Offered

12.10.3 Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Sihuan Pharmaceutical Main Business Overview

12.10.5 Sihuan Pharmaceutical Latest Developments

12.11 Jiangsu Kanion Pharmaceutical

12.11.1 Jiangsu Kanion Pharmaceutical Company Information

12.11.2 Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Product Offered

12.11.3 Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Jiangsu Kanion Pharmaceutical Main Business Overview

12.11.5 Jiangsu Kanion Pharmaceutical Latest Developments

12.12 Shandong Yunmen Pharmaceutical

12.12.1 Shandong Yunmen Pharmaceutical Company Information

12.12.2 Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Product Offered

12.12.3 Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 Shandong Yunmen Pharmaceutical Main Business Overview

12.12.5 Shandong Yunmen Pharmaceutical Latest Developments

13 Research Findings and Conclusion

Table 1. Nimodipine Sustained Release Tablets Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of 30mg/Piece

Table 3. Major Players of 60mg/Piece

Table 4. Major Players of Others

Table 5. Global Nimodipine Sustained Release Tablets Sales by Type (2016-2021) & (K Units)

Table 6. Global Nimodipine Sustained Release Tablets Sales Market Share by Type (2016-2021)

Table 7. Global Nimodipine Sustained Release Tablets Revenue by Type (2016-2021) & ($ million)

Table 8. Global Nimodipine Sustained Release Tablets Revenue Market Share by Type (2016-2021)

Table 9. Global Nimodipine Sustained Release Tablets Sale Price by Type (2016-2021)

Table 10. Global Nimodipine Sustained Release Tablets Sales by Application (2016-2021) & (K Units)

Table 11. Global Nimodipine Sustained Release Tablets Sales Market Share by Application (2016-2021)

Table 12. Global Nimodipine Sustained Release Tablets Value by Application (2016-2021)

Table 13. Global Nimodipine Sustained Release Tablets Revenue Market Share by Application (2016-2021)

Table 14. Global Nimodipine Sustained Release Tablets Sale Price by Application (2016-2021)

Table 15. Global Nimodipine Sustained Release Tablets Sales by Company (2019-2021) & (K Units)

Table 16. Global Nimodipine Sustained Release Tablets Sales Market Share by Company (2019-2021)

Table 17. Global Nimodipine Sustained Release Tablets Revenue by Company (2019-2021) ($ Millions)

Table 18. Global Nimodipine Sustained Release Tablets Revenue Market Share by Company (2019-2021)

Table 19. Global Nimodipine Sustained Release Tablets Sale Price by Company (2019-2021)

Table 20. Key Manufacturers Nimodipine Sustained Release Tablets Producing Area Distribution and Sales Area

Table 21. Players Nimodipine Sustained Release Tablets Products Offered

Table 22. Nimodipine Sustained Release Tablets Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Nimodipine Sustained Release Tablets Sales by Region (2016-2021) (K Units)

Table 26. Global Nimodipine Sustained Release Tablets Sales Market Share by Region (2016-2021)

Table 27. Global Nimodipine Sustained Release Tablets Revenue by Region (2016-2021) & ($ Millions)

Table 28. Global Nimodipine Sustained Release Tablets Revenue Market Share by Region (2016-2021)

Table 29. Americas Nimodipine Sustained Release Tablets Sales by Country (2016-2021) & (K Units)

Table 30. Americas Nimodipine Sustained Release Tablets Sales Market Share by Country (2016-2021)

Table 31. Americas Nimodipine Sustained Release Tablets Revenue by Country (2016-2021) & ($ Millions)

Table 32. Americas Nimodipine Sustained Release Tablets Revenue Market Share by Country (2016-2021)

Table 33. Americas Nimodipine Sustained Release Tablets Sales by Type (2016-2021) & (K Units)

Table 34. Americas Nimodipine Sustained Release Tablets Sales Market Share by Type (2016-2021)

Table 35. Americas Nimodipine Sustained Release Tablets Sales by Application (2016-2021) & (K Units)

Table 36. Americas Nimodipine Sustained Release Tablets Sales Market Share by Application (2016-2021)

Table 37. APAC Nimodipine Sustained Release Tablets Sales by Region (2016-2021) & (K Units)

Table 38. APAC Nimodipine Sustained Release Tablets Sales Market Share by Region (2016-2021)

Table 39. APAC Nimodipine Sustained Release Tablets Revenue by Region (2016-2021) & ($ Millions)

Table 40. APAC Nimodipine Sustained Release Tablets Revenue Market Share by Region (2016-2021)

Table 41. APAC Nimodipine Sustained Release Tablets Sales by Type (2016-2021) & (K Units)

Table 42. APAC Nimodipine Sustained Release Tablets Sales Market Share by Type (2016-2021)

Table 43. APAC Nimodipine Sustained Release Tablets Sales by Application (2016-2021) & (K Units)

Table 44. APAC Nimodipine Sustained Release Tablets Sales Market Share by Application (2016-2021)

Table 45. Europe Nimodipine Sustained Release Tablets Sales by Country (2016-2021) & (K Units)

Table 46. Europe Nimodipine Sustained Release Tablets Sales Market Share by Country (2016-2021)

Table 47. Europe Nimodipine Sustained Release Tablets Revenue by Country (2016-2021) & ($ Millions)

Table 48. Europe Nimodipine Sustained Release Tablets Revenue Market Share by Country (2016-2021)

Table 49. Europe Nimodipine Sustained Release Tablets Sales by Type (2016-2021) & (K Units)

Table 50. Europe Nimodipine Sustained Release Tablets Sales Market Share by Type (2016-2021)

Table 51. Europe Nimodipine Sustained Release Tablets Sales by Application (2016-2021) & (K Units)

Table 52. Europe Nimodipine Sustained Release Tablets Sales Market Share by Application (2016-2021)

Table 53. Middle East & Africa Nimodipine Sustained Release Tablets Sales by Country (2016-2021) & (K Units)

Table 54. Middle East & Africa Nimodipine Sustained Release Tablets Sales Market Share by Country (2016-2021)

Table 55. Middle East & Africa Nimodipine Sustained Release Tablets Revenue by Country (2016-2021) & ($ Millions)

Table 56. Middle East & Africa Nimodipine Sustained Release Tablets Revenue Market Share by Country (2016-2021)

Table 57. Middle East & Africa Nimodipine Sustained Release Tablets Sales by Type (2016-2021) & (K Units)

Table 58. Middle East & Africa Nimodipine Sustained Release Tablets Sales Market Share by Type (2016-2021)

Table 59. Middle East & Africa Nimodipine Sustained Release Tablets Sales by Application (2016-2021) & (K Units)

Table 60. Middle East & Africa Nimodipine Sustained Release Tablets Sales Market Share by Application (2016-2021)

Table 61. Key and Potential Regions of Nimodipine Sustained Release Tablets

Table 62. Key Application and Potential Industries of Nimodipine Sustained Release Tablets

Table 63. Key Challenges of Nimodipine Sustained Release Tablets

Table 64. Key Trends of Nimodipine Sustained Release Tablets

Table 65. Nimodipine Sustained Release Tablets Distributors List

Table 66. Nimodipine Sustained Release Tablets Customer List

Table 67. Global Nimodipine Sustained Release Tablets Sales Forecast by Region (2021-2026) & (K Units)

Table 68. Global Nimodipine Sustained Release Tablets Consumption Market Forecast by Region

Table 69. Global Nimodipine Sustained Release Tablets Revenue Forecast by Region (2021-2026) & ($ millions)

Table 70. Global Nimodipine Sustained Release Tablets Revenue Market Share Forecast by Region (2021-2026)

Table 71. Americas Nimodipine Sustained Release Tablets Sales Forecast by Country (2021-2026) & (K Units)

Table 72. Americas Nimodipine Sustained Release Tablets Revenue Forecast by Country (2021-2026) & ($ millions)

Table 73. APAC Nimodipine Sustained Release Tablets Sales Forecast by Region (2021-2026) & (K Units)

Table 74. APAC Nimodipine Sustained Release Tablets Revenue Forecast by Region (2021-2026) & ($ millions)

Table 75. Europe Nimodipine Sustained Release Tablets Sales Forecast by Country (2021-2026) & (K Units)

Table 76. Europe Nimodipine Sustained Release Tablets Revenue Forecast by Country (2021-2026) & ($ millions)

Table 77. Middle East & Africa Nimodipine Sustained Release Tablets Sales Forecast by Country (2021-2026) & (K Units)

Table 78. Middle East & Africa Nimodipine Sustained Release Tablets Revenue Forecast by Country (2021-2026) & ($ millions)

Table 79. Global Nimodipine Sustained Release Tablets Sales Forecast by Type (2021-2026) & (K Units)

Table 80. Global Nimodipine Sustained Release Tablets Sales Market Share Forecast by Type (2021-2026)

Table 81. Global Nimodipine Sustained Release Tablets Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 82. Global Nimodipine Sustained Release Tablets Revenue Market Share Forecast by Type (2021-2026)

Table 83. Global Nimodipine Sustained Release Tablets Sales Forecast by Application (2021-2026) & (K Units)

Table 84. Global Nimodipine Sustained Release Tablets Sales Market Share Forecast by Application (2021-2026)

Table 85. Global Nimodipine Sustained Release Tablets Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 86. Global Nimodipine Sustained Release Tablets Revenue Market Share Forecast by Application (2021-2026)

Table 87. Bionpharma Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors

Table 88. Bionpharma Nimodipine Sustained Release Tablets Product Offered

Table 89. Bionpharma Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 90. Bionpharma Main Business

Table 91. Bionpharma Latest Developments

Table 92. Arbor Pharmaceuticals Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors

Table 93. Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Product Offered

Table 94. Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 95. Arbor Pharmaceuticals Main Business

Table 96. Arbor Pharmaceuticals Latest Developments

Table 97. Sofgen Pharmaceuticals Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors

Table 98. Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Product Offered

Table 99. Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 100. Sofgen Pharmaceuticals Main Business

Table 101. Sofgen Pharmaceuticals Latest Developments

Table 102. Pharmaceutics International Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors

Table 103. Pharmaceutics International Nimodipine Sustained Release Tablets Product Offered

Table 104. Pharmaceutics International Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 105. Pharmaceutics International Main Business

Table 106. Pharmaceutics International Latest Developments

Table 107. Heritage Pharmaceuticals Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors

Table 108. Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Product Offered

Table 109. Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 110. Heritage Pharmaceuticals Main Business

Table 111. Heritage Pharmaceuticals Latest Developments

Table 112. Bayer Vital Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors

Table 113. Bayer Vital Nimodipine Sustained Release Tablets Product Offered

Table 114. Bayer Vital Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 115. Bayer Vital Main Business

Table 116. Bayer Vital Latest Developments

Table 117. Wuhan HITECK Biopharmaceutical Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors

Table 118. Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Product Offered

Table 119. Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 120. Wuhan HITECK Biopharmaceutical Main Business

Table 121. Wuhan HITECK Biopharmaceutical Latest Developments

Table 122. Qilu Pharmaceutical Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors

Table 123. Qilu Pharmaceutical Nimodipine Sustained Release Tablets Product Offered

Table 124. Qilu Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 125. Qilu Pharmaceutical Main Business

Table 126. Qilu Pharmaceutical Latest Developments

Table 127. Yabao Pharmaceutical Group Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors

Table 128. Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Product Offered

Table 129. Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 130. Yabao Pharmaceutical Group Main Business

Table 131. Yabao Pharmaceutical Group Latest Developments

Table 132. Sihuan Pharmaceutical Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors

Table 133. Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Product Offered

Table 134. Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 135. Sihuan Pharmaceutical Main Business

Table 136. Sihuan Pharmaceutical Latest Developments

Table 137. Jiangsu Kanion Pharmaceutical Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors

Table 138. Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Product Offered

Table 139. Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 140. Jiangsu Kanion Pharmaceutical Main Business

Table 141. Jiangsu Kanion Pharmaceutical Latest Developments

Table 142. Shandong Yunmen Pharmaceutical Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors

Table 143. Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Product Offered

Table 144. Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 145. Shandong Yunmen Pharmaceutical Main Business

Table 146. Shandong Yunmen Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Nimodipine Sustained Release Tablets

Figure 2. Nimodipine Sustained Release Tablets Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Nimodipine Sustained Release Tablets Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Nimodipine Sustained Release Tablets Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Nimodipine Sustained Release Tablets Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of 30mg/Piece

Figure 10. Product Picture of 60mg/Piece

Figure 11. Product Picture of Others

Figure 12. Global Nimodipine Sustained Release Tablets Sales Market Share by Type in 2020

Figure 13. Global Nimodipine Sustained Release Tablets Revenue Market Share by Type (2016-2021)

Figure 14. Nimodipine Sustained Release Tablets Consumed in Hospital

Figure 15. Global Nimodipine Sustained Release Tablets Market: Hospital (2016-2021) & (K Units)

Figure 16. Nimodipine Sustained Release Tablets Consumed in Pharmacy

Figure 17. Global Nimodipine Sustained Release Tablets Market: Pharmacy (2016-2021) & (K Units)

Figure 18. Nimodipine Sustained Release Tablets Consumed in Others

Figure 19. Global Nimodipine Sustained Release Tablets Market: Others (2016-2021) & (K Units)

Figure 20. Global Nimodipine Sustained Release Tablets Sales Market Share by Application (2016-2021)

Figure 21. Global Nimodipine Sustained Release Tablets Revenue Market Share by Application in 2020

Figure 22. Nimodipine Sustained Release Tablets Revenue Market by Company in 2020 ($ Million)

Figure 23. Global Nimodipine Sustained Release Tablets Revenue Market Share by Company in 2020

Figure 24. Global Nimodipine Sustained Release Tablets Sales Market Share by Regions (2016-2021)

Figure 25. Global Nimodipine Sustained Release Tablets Revenue Market Share by Region in 2020

Figure 26. Americas Nimodipine Sustained Release Tablets Sales 2016-2021 (K Units)

Figure 27. Americas Nimodipine Sustained Release Tablets Revenue 2016-2021 ($ Millions)

Figure 28. APAC Nimodipine Sustained Release Tablets Sales 2016-2021 (K Units)

Figure 29. APAC Nimodipine Sustained Release Tablets Revenue 2016-2021 ($ Millions)

Figure 30. Europe Nimodipine Sustained Release Tablets Sales 2016-2021 (K Units)

Figure 31. Europe Nimodipine Sustained Release Tablets Revenue 2016-2021 ($ Millions)

Figure 32. Middle East & Africa Nimodipine Sustained Release Tablets Sales 2016-2021 (K Units)

Figure 33. Middle East & Africa Nimodipine Sustained Release Tablets Revenue 2016-2021 ($ Millions)

Figure 34. Americas Nimodipine Sustained Release Tablets Sales Market Share by Country in 2020

Figure 35. Americas Nimodipine Sustained Release Tablets Revenue Market Share by Country in 2020

Figure 36. Americas Nimodipine Sustained Release Tablets Sales Market Share by Type in 2020

Figure 37. Americas Nimodipine Sustained Release Tablets Sales Market Share by Application in 2020

Figure 38. United States Nimodipine Sustained Release Tablets Revenue Growth 2016-2021 ($ Millions)

Figure 39. Canada Nimodipine Sustained Release Tablets Revenue Growth 2016-2021 ($ Millions)

Figure 40. Mexico Nimodipine Sustained Release Tablets Revenue Growth 2016-2021 ($ Millions)

Figure 41. Brazil Nimodipine Sustained Release Tablets Revenue Growth 2016-2021 ($ Millions)

Figure 42. APAC Nimodipine Sustained Release Tablets Sales Market Share by Region in 2020

Figure 43. APAC Nimodipine Sustained Release Tablets Revenue Market Share by Regions in 2020

Figure 44. APAC Nimodipine Sustained Release Tablets Sales Market Share by Type in 2020

Figure 45. APAC Nimodipine Sustained Release Tablets Sales Market Share by Application in 2020

Figure 46. China Nimodipine Sustained Release Tablets Revenue Growth 2016-2021 ($ Millions)

Figure 47. Japan Nimodipine Sustained Release Tablets Revenue Growth 2016-2021 ($ Millions)

Figure 48. Korea Nimodipine Sustained Release Tablets Revenue Growth 2016-2021 ($ Millions)

Figure 49. Southeast Asia Nimodipine Sustained Release Tablets Revenue Growth 2016-2021 ($ Millions)

Figure 50. India Nimodipine Sustained Release Tablets Revenue Growth 2016-2021 ($ Millions)

Figure 51. Australia Nimodipine Sustained Release Tablets Revenue Growth 2016-2021 ($ Millions)

Figure 52. Europe Nimodipine Sustained Release Tablets Sales Market Share by Country in 2020

Figure 53. Europe Nimodipine Sustained Release Tablets Revenue Market Share by Country in 2020

Figure 54. Europe Nimodipine Sustained Release Tablets Sales Market Share by Type in 2020

Figure 55. Europe Nimodipine Sustained Release Tablets Sales Market Share by Application in 2020

Figure 56. Germany Nimodipine Sustained Release Tablets Revenue Growth 2016-2021 ($ Millions)

Figure 57. France Nimodipine Sustained Release Tablets Revenue Growth 2016-2021 ($ Millions)

Figure 58. UK Nimodipine Sustained Release Tablets Revenue Growth 2016-2021 ($ Millions)

Figure 59. Italy Nimodipine Sustained Release Tablets Revenue Growth 2016-2021 ($ Millions)

Figure 60. Russia Nimodipine Sustained Release Tablets Revenue Growth 2016-2021 ($ Millions)

Figure 61. Middle East & Africa Nimodipine Sustained Release Tablets Sales Market Share by Country in 2020

Figure 62. Middle East & Africa Nimodipine Sustained Release Tablets Revenue Market Share by Country in 2020

Figure 63. Middle East & Africa Nimodipine Sustained Release Tablets Sales Market Share by Type in 2020

Figure 64. Middle East & Africa Nimodipine Sustained Release Tablets Sales Market Share by Application in 2020

Figure 65. Egypt Nimodipine Sustained Release Tablets Revenue Growth 2016-2021 ($ Millions)

Figure 66. South Africa Nimodipine Sustained Release Tablets Revenue Growth 2016-2021 ($ Millions)

Figure 67. Israel Nimodipine Sustained Release Tablets Revenue Growth 2016-2021 ($ Millions)

Figure 68. Turkey Nimodipine Sustained Release Tablets Revenue Growth 2016-2021 ($ Millions)

Figure 69. GCC Country Nimodipine Sustained Release Tablets Revenue Growth 2016-2021 ($ Millions)

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles